Agenzia Regionale di SanitÓ
No verified email
Cited by
Cited by
Idiosyncratic adverse reactions to antiepileptic drugs
G Zaccara, D Franciotta, E Perucca
Epilepsia 48 (7), 1223-1244, 2007
Incidence and predictors of acute symptomatic seizures after stroke
E Beghi, R D'alessandro, S Beretta, D Consoli, V Crespi, L Delaj, ...
Neurology 77 (20), 1785-1793, 2011
Clinical pharmacokinetics of valproic acid—1988
G Zaccara, A Messori, F Moroni
Clinical pharmacokinetics 15 (6), 367-389, 1988
Transcranial magnetic stimulation and epilepsy
CA Tassinari, M Cincotta, G Zaccara, R Michelucci
Clinical neurophysiology 114 (5), 777-798, 2003
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
G Zaccara, E Perucca
Epileptic Disorders 16 (4), 409-431, 2014
The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trials
G Zaccara, P Gangemi, P Perucca, L Specchio
Epilepsia 52 (4), 826-836, 2011
Slow repetitive TMS for drug‐resistant epilepsy: clinical and EEG findings of a placebo‐controlled trial
R Cantello, S Rossi, C Varrasi, M Ulivelli, C Civardi, S Bartalini, G Vatti, ...
Epilepsia 48 (2), 366-374, 2007
Modulation of interhemispheric inhibition by volitional motor activity: an ipsilateral silent period study
F Giovannelli, A Borgheresi, F Balestrieri, G Zaccara, MP Viggiano, ...
The Journal of physiology 587 (22), 5393-5410, 2009
Behavioral and psychological symptoms in Alzheimer’s disease: frequency and relationship with duration and severity of the disease
M Piccininni, A Di Carlo, M Baldereschi, G Zaccara, D Inzitari
Dementia and geriatric cognitive disorders 19 (5-6), 276-281, 2005
Central nervous system adverse effects of new antiepileptic drugs: a meta-analysis of placebo-controlled studies
G Zaccara, PF Gangemi, M Cincotta
Seizure 17 (5), 405-421, 2008
Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis
S Lattanzi, F Brigo, E Trinka, G Zaccara, C Cagnetti, C Del Giovane, ...
Drugs 78 (17), 1791-1804, 2018
Current approaches to the use of generic antiepileptic drugs
G Krńmer, A Biraben, M Carreno, A Guekht, GJ De Haan, J Jędrzejczak, ...
Epilepsy & Behavior 11 (1), 46-52, 2007
Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs
E Perucca, F Albani, G Capovilla, BD Bernardina, R Michelucci, ...
Epilepsia 47, 16-20, 2006
Human heart rate variability and sleep stages
L Toscani, PF Gangemi, A Parigi, R Silipo, P Ragghianti, E Sirabella, ...
The Italian Journal of Neurological Sciences 17 (6), 437-439, 1996
Withdrawal of antiepileptic drugs: Guidelines of the I talian L eague A gainst E pilepsy
E Beghi, G Giussani, S Grosso, A Iudice, AL Neve, F Pisani, LM Specchio, ...
Epilepsia 54, 2-12, 2013
Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long‐term studies?
G Zaccara, A Messori, M Cincotta, G Burchini
Acta neurologica scandinavica 114 (3), 157-168, 2006
Clinical features, pathogenesis and management of drug-induced seizures
G Zaccara, GC Muscas, A Messori
Drug Safety 5 (2), 109-151, 1990
Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta‐analysis of risk factors
E Ferlazzo, S Gasparini, E Beghi, C Sueri, E Russo, A Leo, A Labate, ...
Epilepsia 57 (8), 1205-1214, 2016
The adverse event profile of lacosamide: a systematic review and meta‐analysis of randomized controlled trials
G Zaccara, P Perucca, G Loiacono, F Giovannelli, A Verrotti
Epilepsia 54 (1), 66-74, 2013
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy
M Cincotta, A Borgheresi, C Gambetti, F Balestrieri, L Rossi, G Zaccara, ...
Clinical neurophysiology 114 (10), 1827-1833, 2003
The system can't perform the operation now. Try again later.
Articles 1–20